Leah R. Hanson

The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats.

Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS.

Intranasal tat alters gene expression in the mouse brain.

Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.

Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system.

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease.

Intranasal insulin ameliorates experimental diabetic neuropathy.

Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke.

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS.

Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease.

Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.

Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice.

Motor end plate innervation loss in diabetes and the role of insulin.

Recruiting and retaining family caregivers to a randomized controlled trial on mindfulness-based stress reduction.

Subacute intranasal administration of tissue plasminogen activator increases functional recovery and axonal remodeling after stroke in rats.

Intranasal treatment of neurodegenerative diseases and stroke.

Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states.

Intranasal delivery of growth differentiation factor 5 to the central nervous system.

Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway.

Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration.

Mindfulness-Based Stress Reduction for Family Caregivers: A Randomized Controlled Trial.

Intranasal delivery of insulin via the olfactory nerve pathway.